Lipella Pharmaceuticals Files 8-K
Ticker: LIPO · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1347242
| Field | Detail |
|---|---|
| Company | Lipella Pharmaceuticals Inc. (LIPO) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-event
TL;DR
Lipella Pharma filed an 8-K, but details are scarce. Watch for follow-ups.
AI Summary
Lipella Pharmaceuticals Inc. filed an 8-K on June 16, 2025, reporting an 'Other Event'. The filing does not contain specific details about the event, dollar amounts, or dates beyond the filing date itself. The company's principal executive office is located at 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.
Why It Matters
This filing indicates a material event has occurred for Lipella Pharmaceuticals, but the lack of detail requires further investigation to understand its implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K, which typically reports material events, but the lack of specific information in this filing creates uncertainty.
Key Players & Entities
- Lipella Pharmaceuticals Inc. (company) — Registrant
- June 16, 2025 (date) — Filing Date
- 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208 (location) — Principal Executive Office
- 001-41575 (company_id) — SEC File Number
- 0001347242 (company_id) — Central Index Key
FAQ
What specific event is being reported in this 8-K filing?
The filing is categorized under 'Other Events' but does not provide specific details about the nature of the event.
When was this 8-K filing submitted to the SEC?
The filing was submitted on June 16, 2025.
What is the principal executive office address for Lipella Pharmaceuticals Inc.?
The principal executive office is located at 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.
What is the SEC file number for Lipella Pharmaceuticals Inc.?
The SEC file number is 001-41575.
Does the filing mention any financial figures or dollar amounts?
No, this filing does not contain any specific dollar amounts or financial figures.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding LIPELLA PHARMACEUTICALS INC. (LIPO).